GMP-in-a-box company with Bob Nelsen backing lands $167M to develop its own cancer drugs

For the fourth time in as many weeks, a company focused on portable drug manufacturing is making noise.

This time, Nutcracker Therapeutics has brought in $167 million in a Series C round led by ARCH Venture Partners. The company will use the financing to help advance...

Click to view original post